In the latest trading session, Walgreens Boots Alliance (WBA) closed at $37.09, marking a -1.64% move from the previous day.
In early 2028, pharmacy chain Walgreens Boots Alliance (NASDAQ: WBA) will likely be a larger and more diversified business, assuming its foray into primary care goes according to plan. The pharmacy company finds itself in the midst of an attempt to diversify into providing healthcare services like primary care during a time when its top and bottom lines are looking somewhat weak. As you can see, both its quarterly revenue and net income haven't shown much sign of improvement over the last five years.
One way for companies to bring more traffic to their stores is to provide services that customers can't get from an online retailer like Amazon (NASDAQ: AMZN), which could otherwise easily steal sales away from brick-and-mortar shops. Healthcare could provide such an opportunity, with CVS Health (NYSE: CVS) and Walgreens Boots Alliance (NASDAQ: WBA) making moves in recent years to make it easier for customers to take care of common health issues at their pharmacies rather than having to go to a primary care provider. Big-box retailer Walmart (NYSE: WMT) has gotten into the mix and has begun offering healthcare services at some of its stores.